Learn About Clinician Approaches to Tobacco Cessation on Webcast Series

OSU Wexner Medical Center logo

Learn About Clinician Approaches to Tobacco Cessation on Webcast Series.  Participants will gain an understanding of evidence-based strategies to support patients in quitting tobacco including behavioral interventions and pharmacotherapy options. Actuarily, on average, a woman who smokes a pack of cigarettes a day will live 11 years less than a woman who doesn’t smoke. Men who smoke a pack a day live 12 years less than non-smoking men. If you do the math, that works out to 14 minutes of life lost for every cigarette a person smokes. It’s a childhood epidemic with 90% of smokers beginning before age 18. By the time they are adults, they are fully addicted and quitting becomes very hard because of the severity of nicotine withdrawal symptoms.   But the good news is that we can help ameliorate those symptoms to help patients quit their nicotine habits.

Joining us today are two of the Ohio State University’s tobacco cessation experts. Lindsey Lee is a clinical pharmacist in the Division of General Internal Medicine. And Suzanne Higginbotham is also a clinical pharmacist in the Division of General Internal Medicine.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Understand the health impacts of tobacco use
  • Apply evidence-based cessation strategies and interventions for nicotine dependence
  • Implement appropriate treatment and follow up protocols to enhance patient adherence and reduce relapse

You’ll also learn about the following:

  • Nicotine dependence tests
  • The pharmacist’s role in tobacco cessation
  • Nicotine replacement strategies for the heavy smoker
  • Cytisinicline (cytisine)
  • Pharmacologic approach to inpatients who are smokers
  • Pharmacologic approach to the smoker with coronary artery disease
  • Tobacco cessation and adolescents
  • Weight gain and tobacco cessation
  • E-cigarettes and tobacco cessation
  • Cough increase in the short-term after smoking cessation
  • Tobacco cessation in the habitual marijuana smoker
  • Over the counter pharmacologic therapies
  • Pharmacist prescriptive authority

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual.  You can also e-mail him at derrick.freeman@osumc.edu.

Get Latest Update on Measles on CME Webcast

OSU Wexner Medical Center logo

Get Latest Update on Measles on CME Webcast.  This presentation will review the pathophysiology, clinical presentation, diagnosis, management, and prevention of measles virus infection. Common questions encountered in the outpatient clinic will also be discussed.

For this special program, we’ve brought in a Pediatric Infectious Disease & Epidemiology expert Dr. Matthew Washam.  Dr Washam is the Medical Director of Infection Prevention and Control at Nationwide Children’s Hospital and has presented and published nationwide about the 2022 Columbus Measles outbreak.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Identify the clinical features and complications of measles, such as prodromal symptoms and the characteristic rash phase
  • Describe the diagnostic methods, current management strategies, and preventive measures to control outbreaks

You’ll also learn about the following:

  • Vaccine Efficacy
  • Early Vaccination

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Webcast Producer at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual.  You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Pulmonary Function Testing and Office Based Spirometry on Webcast

OSU Wexner Medical Center logo

Learn About Pulmonary Function Testing and Office Based Spirometry on Webcast. This webcast will discuss Pulmonary Function Testing & Office Based Spirometry. In the first half of the program, learners will gain an understanding of the key updates in the 2022 ATS/ERS pulmonary function test (PFT) guidelines. We will discuss how these revisions differ from the 2005 standards in areas such as test interpretation, reference values, and diagnostic criteria. In the second half viewers should expect to learn key updates in PFT interpretation, including the impact of the new reference standards and revised criteria for classifying severity of impairments and bronchodilator responsiveness. Learners will also appreciate common physiologic impairments on PFTs and develop an approach to interpreting PFTs.

Pulmonary Function Testing can be a useful way to detect and monitor disease. So on this program, we have invited two Ohio State University’s Pulmonary experts to teach us how to interpret PFTs and recent updates to PFT interpretation including the 2022 American Thoracic Society & European Respiratory Society joint guidelines. First, we’d like to welcome Dr Matthew Huang, who is an Assistant Professor of Pulmonary & Critical Care medicine who specializes in treating Asthma and COPD.  Second, we have Dr Gennie Wang joining us. She is the Medical Director of the Pulmonary Function Testing Lab at Ohio State and a clinician-scientist studying Women’s lung health disparities.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • To understand common physiologic impairments on PFTs.
  • To develop an approach to interpreting PFTs.

You’ll also learn about the following:

  • Indications
  • Spirometry vs PFTs
  • 2022 Updates
  • Accurate PFTs

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual.  You can also e-mail him at derrick.freeman@osumc.edu.

Learn How to Approach Oncologic Emergencies

OSU Wexner Medical Center logo

Learn How to Approach Oncologic Emergencies on webcast. This webcast will discuss Oncologic Emergencies. This presentation will review several common oncologic emergencies. The presenters will use case presentations to highlight each condition and review Febrile Neutropenia, Hypercalcemia of Malignancy, Spinal Cord Compression, Tumor Lysis Syndrome, Chemotherapy and Immunotherapy complications. They will also review the clinical guidelines.

To discuss emergencies that we should not miss in our cancer patients, we’ve invited two Ohio State University’s Emergency Medicine Physicians. First, we have Dr. Jason Bischof who is an Associate Professor of Emergency Medicine and in addition to his clinical work, does research. Next, we have Dr. Maegan Reynolds who is also an Associate Professor of Emergency Medicine and is also Pediatric EM trained.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Describe common presentations of oncologic emergencies and review the diagnostic evaluation and management of oncologic emergencies.
  • Discuss advances in oncology treatment and how to approach treatment to rapidly developing new therapies.

You’ll also learn about the following:

  • Disposition
  • Undiagnosed Cancer
  • Cancer vs Complication
  • Immunotherapy

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual.  You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches Learners About Alzheimer’s Disease

OSU Wexner Medical Center logo

CME Webcast Teaches Learners About Alzheimer’s Disease.  Expert Teaches on Artificial Intelligence in Medicine. This program will discuss Alzheimer’s Disease.  This webcast will discuss new developments in our understanding of the pathogenesis and diagnosis of Alzheimer’s Disease. In addition, this webcast will review new treatments for Alzheimer’s Disease, including anti-amyloid monoclonal antibodies.

For more than a century, there was little physicians could do for patients with Alzheimer’s Disease other than diagnose it and provide supportive care. But during the past 2 years, new drugs have been approved by the FDA that appear to actually modify the progression of the disease. On this webcast, we’re going to update you on Alzheimer’s Disease. Joining us is Assistant Professor of Neurology, Dr. Arun Ramamurthy.

What you’ll learn on this webcast

As a result of this educational activity, webcast participants will be able to:

  • Describe Alzheimer’s Disease pathology
  • Discuss current medication options
  • Highlight Alzheimer’s Biomarkers
  • Future directions in diagnosis and treatment

You’ll also learn about the following:

  • Diagnosis of Alzheimer’s Disease
  • Treatment of Alzheimer’s Disease

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Webcast Producer at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual.  You can also e-mail him at derrick.freeman@osumc.edu.